About my research
Sandro Vento is currently Adjunct Full Professor of Medicine at Manash Kozybayev North Kazakhstan University in Petropavlovsk, Kazakhstan, and Adjunct Full Clinical Professor of Medicine at the University of Puthisastra in Phnom Penh, Cambodia. His main research interests are in medical education, particularly in low- and middle-income countries; HIV infection; liver diseases.
All Stories
- How to reduce HIV treatment default in sub-Saharan Africa.
Article
- HIV transmission in sub-Saharan Africa: too much importance has been given to vaginal sex.
Article
- COVID-19 mortality in Africa and Asia
Article
- Medical schools must be strongly improved in many low- and middle-income countries.
Article
- Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure
Article
- The Digital Health Competencies in Medical Education Framework
Article
- Short-Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up
Article
- Trends in publication and collaboration of health-themed systematic reviews before and during the COVID-19 pandemic: A bibliometric study
Article
- Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience
- Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in Ghana
Article
- Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV
Article
- Fulminant hepatitis in low- and middle-income countries.
Article
- HIV-1 RNA levels in semen of people on ‘short-cycle’ antiretroviral therapy
- Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients
- Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
- Medicine should be learned in a conducive environment
- Global research profile on monkeypox-related literature (1962–2022): A bibliometric analysis
- Monkeypox: Immune response, vaccination and preventive efforts
- Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients
- Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, Indonesia
- Acute severe hepatitis of unknown etiology in children: A mini-review
- Global multi-stakeholder endorsement of the MAFLD definition
- Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID‐19 infections?
- Research priorities to reduce the impact of COVID-19 in low- and middle-income countries
Article
- Chronic liver diseases must be reduced worldwide: it is time to act
- Seroprevalence and risk factors for hepatitis B and hepatitis C in three large regions of Kazakhstan
- Short-cycle therapy in HIV-infected adults: rilpivirine combination 4 days on/3 days off therapy
- Prevalence of liver fibrosis using transient elastography in the general population in Cambodia: a pilot study
- Mini-review: Silico-tuberculosis
Article
- Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection
- Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor
- Violence Against Healthcare Workers: A Worldwide Phenomenon With Serious Consequences
- Acute liver failure
Article
- Commentary: Systemic Lupus Erythematosus in Native sub-Saharan Africans: A Systematic Review and Meta-Analysis
- HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa
- Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana’s healthy population
- Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
- Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients
Article
- DRIVE-AHEAD Trial’s Results and the Need for a More Appropriate Comparator Drug
- Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients
- Orphan drugs
- Khat-related liver disease in sub-Saharan Africa: neglected, yet important – Authors' reply
- Patient-centered Care and Treatment in HIV Infection
- Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA?
- Defensive medicine: It is time to finally slow down an epidemic
- Liver cirrhosis in sub-Saharan Africa: neglected, yet important
- “High” antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART
- Detection of Hepatitis E Antibodies in Kazakhstan: A Pilot Study
- The Expanding Therapeutic Perspective of CCR5 Blockade
- Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life
- Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean to Calabria, Italy
- Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV ‐1‐infected patients
- Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up
- Cerebral palsy: a multidisciplinary, integrated approach is essential
- Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient
- End-stage liver disease in eastern Europe and central Asia: action is needed
- Treatment of Acute Liver Failure in Resource-Constrained Settings without Transplantation Facilities Can Be Improved
- Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load
- Tuberculosis-immune reconstitution inflammatory syndrome
- Liver diseases in sub-Saharan Africa: the importance of dedicated public clinics
- Understanding the HIV/AIDS Atripla drug components interaction with human plasma.
- Liver disease in patients with HIV in sub-Saharan Africa
- Raltegravir/nevirapine dual therapy at reduced doses as ‘maintenance’ treatment in virally suppressed HIV-infected patients
- Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act
- Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study
- Virological Efficacy of a Reduced Dose of Nevirapine in a Small Cohort of Suppressed HIV-1–Infected Patients
- Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients: a medium-term follow-up
- Efavirenz dose reduction in HIV-infected patients
- Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up
- Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency
- Management of chronic hepatitis B in children: An unresolved issue
- Comparative chromatography–mass spectrometry studies on the antiretroviral drug nevirapine—Analytical performance characteristics in human plasma determination
- Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancy
- A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1–Infected Patients
- Efficacy of a Reduced Dose of Darunavir/Ritonavir in a Small Cohort of Antiretroviral-Naïve HIV-Infected Patients
- Cancer control in Africa: which priorities?
- Limited Adherence to Antiretroviral Regimens in an Italian Cohort
- Can HIV-1 viral interference be used therapeutically?
- Dose reduction of antiretrovirals: a feasible and testable approach to expand HIV treatment in developing countries
- Isoniazid preventive therapy in human immunodeficiency virus infection [Correspondence]
- Efavirenz dose reduction in HIV-infected patients
- Antiretroviral Therapy-Associated Diseases Are Common in the Long-Term
- A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients
- Efficacy of Lopinavir-Ritonavir Reduced Dose in HIV-Infected Patients
- Tuberculosis and cancer: a complex and dangerous liaison
- Stroke: a realistic approach to a growing problem in sub-Saharan Africa is urgently needed
- Can antiretroviral therapy be safely interrupted and, if so, when?
- Silica Exposure and Silicosis: Action is Needed Now
- Antiretroviral therapy in low-resource settings
- Time for universal HIV and HBV screening for patients with cancer
- Editorial: [Challenges in Infectious Diseases in Low and Middle-Income Countries]
- The challenge of lymphomas in sub-Saharan Africa
- PriorMycobacterium aviumcomplex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy
- Lymph nodes and pathogenesis of infection with HIV-1
- The need for new antibiotics
- No Influence of Nevirapine on Vitamin D Deficiency in HIV-Infected Patients
- The bacterium that could cause cancer
- Diagnosis, management and outcome of clinically- suspected spinal infection
- Maraviroc and CD4+ cell count recovery in patients with virologic suppression and blunted CD4+ cell response
- Human herpesvirus type 6 hepatitis or familiar intrahepatic cholestasis: the importance of follow-up
- Viral Encephalitis: Etiology, Clinical Features, Diagnosis and Management
- Micafungin - The newest echinocandin
- Letter to the Editor: Darunavir-Etravirine-Raltegravir as Salvage Combination Therapy in a Heavily Pretreated HIV-Infected Patient
- Perspectives in therapy for hepatitis C
- Lung infections after cancer chemotherapy
- Aminotransferases as predictors of mortality
- Does tenofovir increase efavirenz hepatotoxicity?
- Initial Hospitalization and Adherence to Highly Active Antiretroviral Therapy
- Voluntary or Universal HIV Testing in Italy?
- Etravirine
- Life-threatening, Multiple Hypersensitivity Reactions Induced by Rifampicin in One Patient with Pulmonary Tuberculosis
- Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption
- Selective Drug Taking During Combination Antiretroviral Therapy
- Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis
- Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults
- Co-occurrence of chronic hepatitis B virus infection and autoimmune hepatitis in a young Senegalese girl
- Tenofovir-Associated Kidney Diseases and Interactions between Tenofovir and Other Antiretrovirals
- Infections and thalassaemia
- Hyperacute Unilateral Gonococcal Endophthalmitis in an HIV-Infected Man without Genital Infection
- Clinical course of infection with hepatitis C
- Human Immunodeficiency Virus-Associated Peripheral Neuropathies
- Interleukin-2 therapy and CD4+ T cells in HIV-1 infection
- Acute liver failure as presenting feature of tyrosinemia type 1 in a child with primary HHV-6 infection
- CHILDHOOD HEPATITIS C VIRUS INFECTION.
- Recreational substance use and tolerance of efavirenz in HIV-1 infected patients
- Cutaneous abscess due to in injection drug user: a case report and review of the literature
- Strongyloidiasis in an HIV‐1–Infected Patient after Highly Active Antiretroviral Therapy–Induced Immune Restoration
- Tipranavir
- Antinuclear antibodies are common in an infectious environment but do not predict systemic lupus erythematosus
- Can We Really Identify HIV-1 Long-Term Nonprogressors?
- Painful Neuropathy Vasculitis in 2 Patients with Long-Standing Human Immunodeficiency Virus-1 Infection
- Early detection of lung cancer in high-risk patients with HIV-1 infection
- Autoimmune hemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection
- Is there a role for viruses in triggering autoimmune hepatitis?
- Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
- Is there a role for TNF-alpha in HIV1-associated lipodystrophy?
- Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected woman
- Management of Health Care Workers With Blood-Borne Infections
- Hepatitis C virus in people with HIV infection
- Blood-Borne Viruses and Health Care Workers
- Sequelae and Serologic Outcome in Persons with Hepatitis B Virus Infection
- Erratum
- Infections and solid organ transplant rejection: a cause-and-effect relationship?
- Hepatitis C is not a sexually transmissible disease
- Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection
- Treatment of autoantibody-associated chronic hepatitis C
- Hepatitis C is not a sexually transmissible disease
- Treatment of autoantibody-associated chronic hepatitis C
- Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue
- Childhood Infections and Autoimmune Diseases
- Does hepatitis C virus cause severe liver disease only in people who drink alcohol?
- How tainted is medicine?
- Full Adherence to HAART: Is It Really Necessary?
- BCG efficacy and tuberculin skin testing
- A Case of Visceral Leishmaniasis with Protracted Incubation in a Nonendemic Area
- Mortality Due to Hepatitis C Virus–Related Cirrhosis in Patients Infected with HIV Type 1: A Role for Alcohol
- MHC Class I Molecules and Progression to AIDS
- Hepatitis A Virus Infection and Atherosclerosis
- Isolated Presence of Antibody to Hepatitis B Core Antigen in Injection Drug Users: Do They Need to Be Vaccinated?
- Tuberculous chorioretinitis
- Failure of lamivudine therapy for chemotherapy-induced reactivation of Hepatitis B
- No Increase in Liver Decompensation Risk with Atypical Hepatitis C Virus Antibody Pattern
- Failure of lamivudine therapy for chemotherapy-induced reactivation of Hepatitis B
- HIV-1 progression in hepatitis-C-infected drug users
- Effect of pregnancy on chronic hepatitis C
- Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis
- Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital
- Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes
- Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
- Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy
- Mediastinal Lymphadenitis due To Cryptococcal Infection In HIV-Positive Patients On Highly Active Antiretroviral Therapy
- Correspondence
- Adherence to HAART in HIV
- Failure of Prophylaxis against PCP in Patients with HIV Infection
- Hepatitis Associated with Hepatitis A Superinfection in Patients with Chronic Hepatitis C
- Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands
- Highly active antiretroviral therapy
- Fluconazole penetration into the prostatic fluid of patients with AIDS- associated cryptococcal meningitis
- Syphilis in prostitutes from Eastern Europe
- Tuberculosis Among Refugees and Displaced People at the Burundi‐Rwanda Border
- Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C
- Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance
- Microsporidium Species in Pulmonary Cavity Lesions of AIDS Patient Infected withRhodococcus equi
- Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS
- The ParaSight™-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria
- Aetiology of pneumonia following isolated closed head injury
- Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C
- Infection with hepatitis G virus in immunoglobulin recipients
- M tuberculosis drug resistance in AIDS
- Resolution of autoimmune hepatitis after bone-marrow transplantation
- Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data
- Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients
- Lack of Sustained Efficacy of Interferon in Patients with Chronic Hepatitis C
- Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus
- Discordant Manifestations of Hepatitis C in Monozygotic Twins
- Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals
- Naturally acquired immunity to Plasmodium falciparum
- Multidrug-Resistant Tuberculosis in Patients With AIDS
- Multidrug-resistant tuberculosis in patients with AIDS
- Pentoxifylline as a Supportive Agent in the Treatment of Cerebral Malaria in Children
- West African Immigrants and New Patterns of Malaria Imported to North Eastern Italy
- Manifestations of TB to CD4 cell counts.
- Prognosis of vertically transmitted pre-core mutant HBV infection
- Pneumocystis carinii pneumonia during primary HIV-1 infection
- Rapid decline of CD4+ cells after IFNα treatment in HIV-1 infection
- Transmission of HIV-Associated Tuberculosis to Healthcare Workers
- Hepatitis C viraemia with normal liver histology in symptomless HIV-1 infection
- Use of fluconazole in the treatment ofCandida albicans hydrocephalus shunt infection
- Failure of the 12 months course of antituberculous chemoprophylaxis in HIV infection
- Tuberculosis and HIV Infection
- Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals
- Survival after Active Tuberculosis in Patients with HIV Infection
- Cellular mechanisms of hepatocyte damage and regulatory mechanisms in autoimmune chronic active hepatitis
- Type 2 autoimmune hepatitis and hepatitis C virus infection
- HAZARDS OF INTERFERON THERAPY FOR HBV-SERONEGATIVE CHRONIC HEPATITIS
- REACTIVATION OF HEPATITIS B IN AIDS
- CLINICAL REACTIVATION OF HEPATITIS B IN ANTI-HBs-POSITIVE PATIENTS WITH AIDS
- PATHOGENESIS OF TYPE I DIABETES
- Serial study of liver-directed autoantibodies and autoreactive T-lymphocytes in acute viral hepatitis B
- Sequential studies of pre-S2 antigenemia and anti-pre-S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phase
- In vitro effect of TP-1 (a calf thymic extract) on suppressor T-cell function of patients with autoimmune chronic active hepatitis
- Relevance of immune mediated mechanisms in progressive alcoholic liver injury
- PROSPECTIVE STUDY OF CELLULAR IMMUNITY TO HEPATITIS-B-VIRUS ANTIGENS FROM THE EARLY INCUBATION PHASE OF ACUTE HEPATITIS B
- T-CELL INDUCERS OF SUPPRESSOR LYMPHOCYTES CONTROL LIVER-DIRECTED AUTOREACTIVITY
- CELL-MEDIATED IMMUNITY AND SUPPRESSOR-T-CELL DEFECTS TO LIVER-DERIVED ANTIGENS IN FAMILIES OF PATIENTS WITH AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
- T lymphocyte sensitization to hbcag and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease
- ANTIGEN SPECIFIC SUPPRESSOR CELL FUNCTION IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS